This is in line with previous studies showing better DFS and/or OS for patients with high PD-L1 expression [40] in tumour cells [44,47,61], immune cells [36,43,48,56,74], or both [36,46] (Supplementary Table S8). Here, CD274 is linked to neoplasm.